Lucas R

References (4)

Title : Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview - Marrero_2011_Pharm.Res_28_413
Author(s) : Marrero MB , Bencherif M , Lippiello PM , Lucas R
Ref : Pharm Res , 28 :413 , 2011
Abstract : Marrero_2011_Pharm.Res_28_413
ESTHER : Marrero_2011_Pharm.Res_28_413
PubMedSearch : Marrero_2011_Pharm.Res_28_413
PubMedID: 20859658

Title : Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases - Bencherif_2011_Cell.Mol.Life.Sci_68_931
Author(s) : Bencherif M , Lippiello PM , Lucas R , Marrero MB
Ref : Cell Mol Life Sciences , 68 :931 , 2011
Abstract : Bencherif_2011_Cell.Mol.Life.Sci_68_931
ESTHER : Bencherif_2011_Cell.Mol.Life.Sci_68_931
PubMedSearch : Bencherif_2011_Cell.Mol.Life.Sci_68_931
PubMedID: 20953658

Title : An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes - Marrero_2010_J.Pharmacol.Exp.Ther_332_173
Author(s) : Marrero MB , Lucas R , Salet C , Hauser TA , Mazurov A , Lippiello PM , Bencherif M
Ref : Journal of Pharmacology & Experimental Therapeutics , 332 :173 , 2010
Abstract : Marrero_2010_J.Pharmacol.Exp.Ther_332_173
ESTHER : Marrero_2010_J.Pharmacol.Exp.Ther_332_173
PubMedSearch : Marrero_2010_J.Pharmacol.Exp.Ther_332_173
PubMedID: 19786623

Title : The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease - Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
Author(s) : Bodick NC , Offen WW , Shannon HE , Satterwhite J , Lucas R , van Lier R , Paul SM
Ref : Alzheimer Disease & Associated Disorders , 11 Suppl 4 :S16 , 1997
Abstract : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
ESTHER : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
PubMedSearch : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
PubMedID: 9339268